Achievement of treatment effectiveness criteria 12 months post-index | TNFi cyclers | Non-TNFi switchers | P value |
---|---|---|---|
(n=5,020) | (n=1,925) | ||
Achieved all criteria | 24.0% | 27.8% | 0.001 |
≥80% Adherence | 40.0% | 41.7% | 0.182 |
No dose increase | 88.3% | 96.7% | <0.001 |
No switch to another bDMARD | 65.4% | 70.3% | <0.001 |
No new conventional DMARD | 84.7% | 85.6% | 0.353 |
No new/increased oral glucocorticoid | 85.7% | 84.7% | 0.285 |
<2 Glucocorticoid injections in first 90 days | 90.6% | 90.6% | 0.968 |